Why the study?
Advances in cancer treatment, common cardiovascular risk factors, and population ageing have increased the number of cancer patients presenting with acute cardiovascular diseases.
This consensus statement provides expert guidance on managing acute heart failure, myocardial diseases, venous thromboembolism, and arrhythmias in the growing population of cardio-oncology patients.
Acute cardiac specialists must integrate individualized multidisciplinary protocols for cancer-related ACS and pericardial disease; extends cardio-oncology into acute care guidelines.
Advances in treatment, common cardiovascular (CV) risk factors and the ageing of the population have led to an increasing number of cancer patients presenting with acute CV diseases. These events may be related to cancer itself or cancer treatment. Acute cardiac care specialists must be aware of these acute CV complications and be able to manage them. This may require an individualized and multidisciplinary approach. The management of acute coronary syndromes and acute pericardial diseases in cancer patients was covered in part 1 of a clinical consensus document. This second part focusses on acute heart failure, acute myocardial diseases, venous thromboembolic diseases and acute arrhythmias.
No takes yet. Share an insight, caveat, or question.
Gevaert et al. (2022) conducted a review in Acute cardiovascular disease in cancer patients. Evaluation and management of acute cardiovascular diseases was evaluated. This clinical consensus statement outlines the evaluation and management of acute heart failure, acute myocardial diseases, venous thromboembolic diseases, and acute arrhythmias in cancer patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: